Asia-Pacific biotechnology market is estimated to grow at a CAGR of 7.1% during the forecast period. The biotechnology industry in Asia-Pacific was valued at $94 billion in 2019 and anticipated to grow significantly during the forecast period. Countries in Asia-Pacific that are contributing to the market growth include China, India, and Japan. The rising healthcare expenditure, the increasing R&D and investments by big pharmaceutical companies in life science research are some factors that are driving the market growth in the region. Asia-Pacific region despite the economic slowdown in economies such as in India; the increasing public health care programs including the increasing private wealth is expected to boost the region’s health care spending. Moreover, the growing demand for advanced healthcare facilities in emerging economies such as China, and collaboration among the market players for the development of innovative products are some other factors that are significantly contributing to the market growth.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/asia-pacific-biotechnology-market
Asia-Pacific biotechnology market is classified on the basis of type. Based on type, the market is segmented into healthcare, crop production and agriculture, industrial, natural resources & environment, and others. Among these applications, biotechnology finds its significant application in healthcare in the study of genes. Many organizations are now involved in collecting, processing, distribution, and storage of human tissues to aid investigators in biomedical research.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/asia-pacific-biotechnology-market
Geographically, the Asia-Pacific biotechnology market is analyzed for China, Japan, India, and the Rest of Asia-Pacific. China contributed the major share in the Asia-Pacific biotechnology market in 2019 and is expected to retain its position during the forecast period. The dominance of China in the Asia-Pacific market is mainly due to the presence of a substantial health workforce in the country. India is projected to exhibit a considerable CAGR in the Asia-Pacific biotechnology market during the forecast period, owing to the rising medical tourism in the country.
The companies which are contributing to the growth of the Asia-Pacific biotechnology market include Amgen Inc., Novo Nordisk A/S, CSL Ltd., Bristol-Myers Squibb Co., AstraZeneca PLC, Merck & Co., Inc., Johnson & Johnson Services Inc., and Pfizer Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market.
Market Segmentation
Asia-Pacific Biotechnology Market by Type
• Healthcare
• Crop Production and Agriculture
• Industrial
• Natural Resources & Environment
• Others (Bioinformatics)
Regional Analysis
• China
• Japan
• India
• Rest of Asia-Pacific
Company Profiles
• Abbott Laboratories
• AbbVie, Inc.
• Alkermes PLC
• Amgen, Inc.
• AstraZeneca PLC
• Biogen, Inc.
• Bristol-Myers Squibb Co.
• CSL, Ltd.
• F. Hoffmann La-Roche, Ltd.
• Johnson & Johnson Services, Inc.
• Novartis AG
• Novo Nordisk A/S
• Pfizer, Inc.
• Regeneron Pharmaceuticals, Inc.
• Sanofi S.A.
• Thermo Fisher Scientific, Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-biotechnology-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404